Predictive Analytics:
Accurate and Actionable

In any population, be it a community, a health plan, an employer, an educational institution, even a faith community, there are those with undetected, uncontrolled, or misdiagnosed chronic conditions. Not only do they represent a guaranteed financial risk, with COVID-19, their risk of catastrophic health events, even death, is many times higher.

Just as important as identifying chronic disease risk is helping communities understand their COVID-19 risk.

Decode Health uses unique data structuring and modeling techniques to identify and track disease risk resulting in actionable insights to help those who care for chronic disease populations. And actionable insights to help communities mitigate COVID-19 spread.

How We Do It

Tackling chronic disease and COVID-19 accurately requires the investigative minds of immunologists AND the analytical speed, scale and efficiency of machine learning.
Decode Health is one of the few companies in the world that has both. That’s what sets us apart.


Client sends healthcare claims and other structured data


Decode layers its proprietary data + social determinants of health


Decode trains, tests, and optimizes models to uncover patterns and score populations


Decode identifies at-risk patients and delivers actionable information to care teams


Care teams engage at-risk patients to provide education and impact treatment plans

The Bottom Line

Example: Autoimmune Disease Cost Savings Analysis


Average total healthcare
spend PMPY

$15K – $125K

Range of autoimmune
spend PMPY


Savings potential
on annual autoimmune spend


Projected ROI
using Decode’s platform

Find Your Chronic
Disease Problem

Sample Impact from Autoimmune Disease

  • Up to 16% of your managed population has one of the diseases and conditions we detect and monitor.
  • They cost your plans and employers millions.
  • Savings from correcting misdiagnosis is significant in the first year.
  • 25% of claims are categorized with ill-defined R diagnosis codes and some of that population will likely have an autoimmune or chronic  disease.
Contact Us